These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 1723767)
21. Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity. Uprichard AC; Chi LG; Kitzen JM; Lynch JJ; Frye JW; Lucchesi BR J Pharmacol Exp Ther; 1989 Nov; 251(2):571-7. PubMed ID: 2572693 [TBL] [Abstract][Full Text] [Related]
22. Electrophysiological and anatomic differences between canine hearts with inducible ventricular tachycardia and fibrillation associated with chronic myocardial infarction. Denniss AR; Richards DA; Waywood JA; Yung T; Kam CA; Ross DL; Uther JB Circ Res; 1989 Jan; 64(1):155-66. PubMed ID: 2909298 [TBL] [Abstract][Full Text] [Related]
24. Nonsustained polymorphic ventricular tachycardia induced by electrical stimulation in 3 week old canine myocardial infarction. Garan H; Fallon JT; Ruskin JN Am J Cardiol; 1981 Aug; 48(2):280-6. PubMed ID: 7270437 [TBL] [Abstract][Full Text] [Related]
25. Electrotonic remodeling following myocardial infarction in dogs susceptible and resistant to sudden cardiac death. Del Rio CL; McConnell PI; Kukielka M; Dzwonczyk R; Clymer BD; Howie MB; Billman GE J Appl Physiol (1985); 2008 Feb; 104(2):386-93. PubMed ID: 18048585 [TBL] [Abstract][Full Text] [Related]
26. Demonstration of proarrhythmic activity with the class IC antiarrhythmic agent encainide in a canine model of previous myocardial infarction. Wallace AA; Stupienski RF; Kothstein T; Gehret JR; Lynch JJ J Cardiovasc Pharmacol; 1993 Mar; 21(3):397-404. PubMed ID: 7681500 [TBL] [Abstract][Full Text] [Related]
27. Nature of inducible ventricular tachyarrhythmias in a canine chronic myocardial infarction model. Echt DS; Griffin JC; Ford AJ; Knutti JW; Feldman RC; Mason JW Am J Cardiol; 1983 Nov; 52(8):1127-32. PubMed ID: 6637836 [TBL] [Abstract][Full Text] [Related]
28. A model of chronic ischemic arrhythmias: the relation between electrically inducible ventricular tachycardia, ventricular fibrillation threshold and myocardial infarct size. Gang ES; Bigger JT; Livelli FD Am J Cardiol; 1982 Sep; 50(3):469-77. PubMed ID: 7113930 [TBL] [Abstract][Full Text] [Related]
29. Significance of repeat programmed ventricular stimulation at electrophysiology study for arrhythmia prediction after acute myocardial infarction. Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P Pacing Clin Electrophysiol; 2014 Jul; 37(7):795-802. PubMed ID: 24666010 [TBL] [Abstract][Full Text] [Related]
30. Serial analysis of spontaneous and induced ventricular arrhythmias in a canine model of myocardial infarction. Nogami A; Taniguchi K; Takeuchi J Jpn Heart J; 1988 Jul; 29(4):437-53. PubMed ID: 3184454 [TBL] [Abstract][Full Text] [Related]
32. MS-551 protects against ventricular fibrillation in a chronic canine model of sudden cardiac death. Friedrichs GS; Chi L; Gralinski MR; Black SC; Basler GC; Mu DX; Pewitt SR; Johnson CR; Lucchesi BR J Cardiovasc Pharmacol; 1995 Feb; 25(2):314-23. PubMed ID: 7752658 [TBL] [Abstract][Full Text] [Related]
33. Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death. Fiedler VB; Mardin M Basic Res Cardiol; 1986; 81(1):40-53. PubMed ID: 3521579 [TBL] [Abstract][Full Text] [Related]
34. Epicardial ganglionated plexi ablation increases the inducibility of ventricular tachyarrhythmias in a canine postmyocardial infarction model. Wu B; Xu S; Dai R; Hong M; Wu H; Lin R J Cardiovasc Electrophysiol; 2019 May; 30(5):741-746. PubMed ID: 30957344 [TBL] [Abstract][Full Text] [Related]
35. The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent. Black SC; Chi LG; Mu DX; Lucchesi BR J Pharmacol Exp Ther; 1991 Aug; 258(2):416-23. PubMed ID: 1865349 [TBL] [Abstract][Full Text] [Related]
36. Antifibrillatory actions of d,l-nadolol in a conscious canine model of sudden coronary death. Patterson E; Lucchesi BR J Cardiovasc Pharmacol; 1983; 5(5):737-44. PubMed ID: 6195459 [TBL] [Abstract][Full Text] [Related]
37. Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine model. Issa ZF; Zhou X; Ujhelyi MR; Rosenberger J; Bhakta D; Groh WJ; Miller JM; Zipes DP Circulation; 2005 Jun; 111(24):3217-20. PubMed ID: 15956128 [TBL] [Abstract][Full Text] [Related]
38. Triphasic time dependence of prognostic markers in patients with sustained ventricular tachyarrhythmias and coronary artery disease. Nogami A; Rozanski JJ; Furukawa T; Gosselin AJ; Lister JW Jpn Circ J; 1989 Sep; 53(9):1061-71. PubMed ID: 2600998 [TBL] [Abstract][Full Text] [Related]
39. Effects of diltiazem upon experimental ventricular dysrhythmias. Patterson E; Eller BT; Lucchesi BR J Pharmacol Exp Ther; 1983 Apr; 225(1):224-33. PubMed ID: 6834274 [TBL] [Abstract][Full Text] [Related]
40. Arrhythmia inducibility and ventricular vulnerability in a chronic feline infarction model. Wetstein L; Mark R; Kelliher GJ; Friehling T; O'Connor KM; Kowey PR Am Heart J; 1985 Nov; 110(5):955-60. PubMed ID: 4061270 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]